Adagio Therapeutics

1 Follower


Adagio Therapeutics, Inc. is a clinical-stage a biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses.

Tillman Gerngross
Co-Founder & CEO
Tillman Gerngross
Laura Walker
Co-Founder & Chief Scientific Officer
Becky Dabora
Chief Technology & Manufacturing Officer
Lynn Connolly
Chief Medical Officer
Ellie Hershberger
Chief Development Officer
Eric Kimble
Chief Commercial Officer
Ed Campanaro
SVP, Clinical Operations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.